EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Antinociceptive Behavior, Glutamine/Glutamate, and Neopterin in Early-Stage Streptozotocin-Induced Diabetic Neuropathy in Liraglutide-Treated Mice under a Standard or Enriched Environment

Pavlina Gateva iD, Milen Hristov iD, Natasha Ivanova, Debora Vasileva iD, Alexandrina Ivanova, Zafer Sabit, Todor Bogdanov iD, Sonia Apostolova, Rumiana Tzoneva iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms251910786 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Pavlina Gateva und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Toxicology, Faculty of Medicine, Medical University of Sofia, 1431 Sofia, Bulgaria. Hauptthemen laut MEDLINE: Liraglutide, Diabetic Neuropathies, Glutamine, Diabetes Mellitus, Experimental. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical University of Sofia, Bulgarian Science Fund, Council of Medical Science, Medical University of Sofia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diabetic neuropathy (DN) is a common complication of long-lasting type 1 and type 2 diabetes, with no curative treatment available. Here, we tested the effect of the incretin mimetic liraglutide in DN in mice with early-stage type 1 diabetes bred in a standard laboratory or enriched environment. With a single i.p. injection of streptozotocin 150 mg/kg, we induced murine diabetes. Liraglutide (0.4 mg/kg once daily, i.p. for ten days since the eighth post-streptozotocin day) failed to decrease the glycemia in the diabetic mice; however, it alleviated their antinociceptive behavior, as tested with formalin. The second phase of the formalin test had significantly lower results in liraglutide-treated mice reared in the enriched environment vs. liraglutide-treated mice under standard conditions [2.00 (0.00–11.00) vs. 29.00 (2.25–41.50) s, p = 0.016]. Liraglutide treatment, however, decreased the threshold of reactivity in the von Fray test. A significantly higher neopterin level was demonstrated in the diabetic control group compared to treatment-naïve controls and the liraglutide-treated diabetic mice (p < 0.001). The glutamine/glutamate ratio in both liraglutide-treated groups, either reared under standard conditions (p = 0.003) or an enriched environment (p = 0.002), was significantly higher than in the diabetic controls. This study demonstrates an early liraglutide effect on pain sensation in two streptozotocin-induced diabetes mouse models by reducing some inflammatory and oxidative stress parameters.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LiraglutideDiabetic NeuropathiesGlutamineDiabetes Mellitus, ExperimentalGlutamic AcidNeopterinAnimalsMiceMaleStreptozocinAnalgesics

Stichwörter der Autor:innen

diabetesenriched environmentglutamine-to-glutamate ratioliraglutidemiceneopterinneuropathystreptozotocin

Substanzen

LiraglutideGlutamineGlutamic AcidNeopterinStreptozocinAnalgesics

Autor:innen und Institutionen

  • Department of Pharmacology and Toxicology, Faculty of Medicine, Medical University of Sofia, 1431 Sofia, Bulgaria.
  • Institute of Neurobiology, Bulgarian Academy of Sciences, 1113 Sofia, Bulgaria.
  • Department of Pathophysiology, Faculty of Medicine, Medical University of Sofia, 1431 Sofia, Bulgaria.
  • Department of Medical Physics and Biophysics, Medical University of Sofia, 1431 Sofia, Bulgaria.
  • Institute of Biophysics and Biomedical Engineering, Bulgarian Academy of Sciences, 1113 Sofia, Bulgaria.

ORCID-Profile: Pavlina Gateva, Milen Hristov, Debora Vasileva, Todor Bogdanov, Rumiana Tzoneva

Förderung

  • Medical University of Sofia
  • Bulgarian Science Fund
  • Council of Medical Science, Medical University of Sofia
  • Bulgarian National Science Fund

Zitieren

APA

Gateva, P., Hristov, M., Ivanova, N., Vasileva, D., Ivanova, A., Sabit, Z., Bogdanov, T., Apostolova, S., & Tzoneva, R. (2024). Antinociceptive Behavior, Glutamine/Glutamate, and Neopterin in Early-Stage Streptozotocin-Induced Diabetic Neuropathy in Liraglutide-Treated Mice under a Standard or Enriched Environment. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms251910786

Vancouver

Gateva P, Hristov M, Ivanova N, Vasileva D, Ivanova A, Sabit Z, et al. Antinociceptive Behavior, Glutamine/Glutamate, and Neopterin in Early-Stage Streptozotocin-Induced Diabetic Neuropathy in Liraglutide-Treated Mice under a Standard or Enriched Environment. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms251910786

BibTeX
@article{Gateva2024,
  author = {Gateva, Pavlina and Hristov, Milen and Ivanova, Natasha and Vasileva, Debora and Ivanova, Alexandrina and Sabit, Zafer and Bogdanov, Todor and Apostolova, Sonia and Tzoneva, Rumiana},
  title = {Antinociceptive Behavior, Glutamine/Glutamate, and Neopterin in Early-Stage Streptozotocin-Induced Diabetic Neuropathy in Liraglutide-Treated Mice under a Standard or Enriched Environment},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms251910786}
}
Kostenlos starten →